News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
497,349 Results
Type
Article (36928)
Company Profile (320)
Press Release (460101)
Multimedia
Podcasts (71)
Webinars (9)
Section
Business (142155)
Career Advice (1388)
Deals (27595)
Drug Delivery (105)
Drug Development (73072)
Employer Resources (116)
FDA (11566)
Job Trends (10482)
News (258570)
Policy (27807)
Tag
Academia (2133)
Accelerated approval (5)
Adcomms (25)
Allergies (81)
Alliances (45730)
ALS (82)
Alzheimer's disease (1343)
Antibody-drug conjugate (ADC) (131)
Approvals (11553)
Artificial intelligence (204)
Autoimmune disease (23)
Automation (9)
Bankruptcy (265)
Best Places to Work (8794)
BIOSECURE Act (17)
Biosimilars (91)
Biotechnology (252)
Bladder cancer (77)
Brain cancer (30)
Breast cancer (239)
Cancer (2068)
Cardiovascular disease (167)
Career advice (1168)
Career pathing (20)
CAR-T (152)
Cell therapy (412)
Cervical cancer (19)
Clinical research (59022)
Collaboration (795)
Company closure (1)
Compensation (487)
Complete response letters (27)
COVID-19 (2577)
CRISPR (46)
C-suite (201)
Cystic fibrosis (95)
Data (2008)
Decentralized trials (1)
Denatured (15)
Depression (44)
Diabetes (263)
Diagnostics (4115)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (36)
Drug discovery (111)
Drug pricing (108)
Drug shortages (29)
Duchenne muscular dystrophy (99)
Earnings (51568)
Editorial (41)
Employer branding (14)
Employer resources (106)
Events (71688)
Executive appointments (568)
FDA (12656)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (655)
Gene editing (109)
Generative AI (15)
Gene therapy (310)
GLP-1 (743)
Government (4270)
Grass and pollen (5)
Guidances (52)
Healthcare (13675)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (127)
Indications (28)
Infectious disease (2729)
Inflammatory bowel disease (129)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (88)
Interviews (240)
IPO (12706)
IRA (46)
Job creations (2106)
Job search strategy (1005)
Kidney cancer (8)
Labor market (19)
Layoffs (378)
Leadership (12)
Legal (7287)
Liver cancer (61)
Lung cancer (294)
Lymphoma (139)
Machine learning (7)
Management (35)
Manufacturing (267)
MASH (71)
Medical device (7296)
Medtech (7298)
Mergers & acquisitions (15388)
Metabolic disorders (699)
Multiple sclerosis (75)
NASH (22)
Neurodegenerative disease (95)
Neuropsychiatric disorders (31)
Neuroscience (1871)
NextGen: Class of 2025 (4519)
Non-profit (3110)
Now hiring (23)
Obesity (380)
Opinion (217)
Ovarian cancer (71)
Pain (67)
Pancreatic cancer (72)
Parkinson's disease (145)
Partnered (15)
Patents (204)
Patient recruitment (95)
Peanut (46)
People (38436)
Pharmaceutical (58)
Pharmacy benefit managers (12)
Phase I (18784)
Phase II (26146)
Phase III (19409)
Pipeline (1134)
Policy (147)
Postmarket research (2034)
Preclinical (8035)
Press Release (44)
Prostate cancer (95)
Psychedelics (36)
Radiopharmaceuticals (255)
Rare diseases (382)
Real estate (3271)
Recruiting (49)
Regulatory (18285)
Reports (25)
Research institute (1913)
Resumes & cover letters (205)
Rett syndrome (5)
RNA editing (5)
RSV (48)
Schizophrenia (75)
Series A (114)
Series B (72)
Service/supplier (4)
Sickle cell disease (54)
Special edition (12)
Spinal muscular atrophy (148)
Sponsored (23)
Startups (2732)
State (1)
Stomach cancer (12)
Supply chain (61)
Tariffs (35)
The Weekly (55)
Vaccines (755)
Venture capitalists (38)
Weight loss (266)
Women's health (20)
Worklife (12)
Date
Today (120)
Last 7 days (766)
Last 30 days (2180)
Last 365 days (27710)
2025 (9080)
2024 (29547)
2023 (32866)
2022 (42104)
2021 (45098)
2020 (41714)
2019 (33750)
2018 (25326)
2017 (24806)
2016 (23021)
2015 (26825)
2014 (20473)
2013 (16335)
2012 (17008)
2011 (17646)
2010 (16406)
Location
Africa (606)
Alabama (49)
Alaska (5)
Arizona (129)
Arkansas (8)
Asia (30992)
Australia (5499)
California (5108)
Canada (1640)
China (474)
Colorado (206)
Connecticut (224)
Delaware (135)
Europe (72720)
Florida (706)
Georgia (173)
Hawaii (1)
Idaho (36)
Illinois (391)
India (25)
Indiana (225)
Iowa (9)
Japan (137)
Kansas (80)
Kentucky (17)
Louisiana (12)
Maine (33)
Maryland (801)
Massachusetts (3930)
Michigan (125)
Minnesota (228)
Mississippi (1)
Missouri (58)
Montana (24)
Nebraska (11)
Nevada (49)
New Hampshire (29)
New Jersey (1476)
New Mexico (19)
New York (1454)
North Carolina (756)
North Dakota (6)
Northern California (2261)
Ohio (151)
Oklahoma (11)
Oregon (25)
Pennsylvania (1042)
Puerto Rico (9)
Rhode Island (22)
South America (847)
South Carolina (12)
South Dakota (1)
Southern California (1928)
Tennessee (60)
Texas (654)
United States (18629)
Utah (106)
Virginia (126)
Washington D.C. (46)
Washington State (439)
West Virginia (2)
Wisconsin (36)
497,349 Results for "affimed therapeutics ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting
April 24, 2025
·
2 min read
Press Releases
Affimed to Present at the Leerink Partners Global Healthcare Conference 2025
March 4, 2025
·
1 min read
Press Releases
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting
April 30, 2025
·
4 min read
Press Releases
Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting
March 25, 2025
·
2 min read
Press Releases
Bacteria in Our Aging Guts Can Elevate Risk of Leukemia
April 24, 2025
·
7 min read
Business
Affimed Reports First Quarter 2024 Financial Results & Business Update
Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported financial results and provided an update on clinical and corporate progress for the quarter ended March 31, 2024.
June 12, 2024
·
15 min read
Press Releases
Affimed Reports Third Quarter 2024 Financial Results & Business Update
November 15, 2024
·
13 min read
Press Releases
Luminopia Announces FDA Clearance for Patients with Amblyopia Aged 8 to 12 Years
April 22, 2025
·
5 min read
Affimed Announces Annual General Meeting of Shareholders - May 28, 2024
Affimed N.V. announced that its 2024 Annual General Meeting of Shareholders will be held on June 26, 2024 at 09:00 a.m. CET at the offices of De Brauw Blackstone Westbroek N.V., Burgerweeshuispad 201, 1076 GR Amsterdam, the Netherlands.
May 28, 2024
·
1 min read
Press Releases
Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk
March 31, 2025
·
9 min read
1 of 49,735
Next
